Macular pigment carotenoids in the retina and occipital cortex are related in humans

Nutritional Neuroscience

Volumn 19, Issue 3, 2016, Pages 95-101

  Vishwanathan, Rohini ^a   Schalch, Wolfgang ^b   Johnson, Elizabeth J ^a  

^a TUFTS UNIVERSITY   (United States)

^b DSM NUTRITIONAL PRODUCTS LTD   (Switzerland)

Author keywords

Brain; Cognition; Lutein; Macular pigment; Meso zeaxanthin; Retina; Zeaxanthin

Indexed keywords

MESO ZEAXANTHIN; UNCLASSIFIED DRUG; VISUAL PIGMENT; XANTHOPHYLL; ZEAXANTHIN; BIOLOGICAL MARKER; MESO-ZEAXANTHIN;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; COGNITION; CONTROLLED STUDY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; MALE; OCCIPITAL CORTEX; PRIORITY JOURNAL; RETINA; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ANTIBODY SPECIFICITY; COMPARATIVE STUDY; HIPPOCAMPUS; ISOLATION AND PURIFICATION; METABOLISM; MIDDLE AGED; NERVE CELL; REPRODUCIBILITY; TISSUE BANK; VERY ELDERLY; VISUAL CORTEX;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BIOMARKERS; COGNITION; FEMALE; HIPPOCAMPUS; HUMANS; LUTEIN; MALE; MIDDLE AGED; NEURONS; ORGAN SPECIFICITY; REPRODUCIBILITY OF RESULTS; RETINA; RETINAL PIGMENTS; TISSUE BANKS; VISUAL CORTEX; ZEAXANTHINS;

EID: 84962061548     PISSN: 1028415X     EISSN: 14768305     Source Type: Journal    
DOI: 10.1179/1476830514Y.0000000141     Document Type: Article

References (25)

1. Ahmed SS, Lott MN, Marcus DM. The macular xanthophylls. Surv Ophthalmol 2005;50(2):183–93.
2. Bone RA, Landrum JT, Fernandez L, Tarsis SL. Analysis of the macular pigment by HPLC: retinal distribution and age study. Invest Ophthalmol Vis Sci 1988;29(6):843–9.
3. Bone RA, Landrum JT, Hime GW, Cains A, Zamor J. Stereochemistry of the human macular carotenoids. Invest Ophthalmol Vis Sci 1993;34(6):2033–40.
4. Johnson EJ, Neuringer M, Russell RM, Schalch W, Snodderly DM. Nutritional manipulation of primate retinas, III: effects of lutein or zeaxanthin supplementation on adipose tissue and retina of xanthophyll-free monkeys. Invest Ophthalmol Vis Sci 2005;46(2):692–702.
5. Barker FM, Snodderly DM, Johnson EJ, et al. Nutritional manipulation of primate retinas, V: effects of lutein, zeaxanthin, and n-3 fatty acids on retinal sensitivity to blue-light–induced damage. Invest Ophthalmol Vis Sci 2011;52(7):3934–42
6. Krinsky NI. Antioxidant function of carotenoids. Free Radic Biol Med 1989;7(6):617–35.
7. Bone RA, Landrum JT, Mayne ST, Gomez CM, Tibor SE, Twaroska EE. Macular pigment in donor eyes with and without AMD: a case-control study. [Erratum appears in Invest Ophthalmol Vis Sci 2001 Mar;42(3):548]. Invest Ophthalmol Vis Sci 2001;42(1):235–40.
8. Klein R, Klein BEK, Jensen SC, Mares-Perlman JA, Cruickshanks KJ, Palta M. Age-related maculopathy in a multiracial United States population. The National Health and Nutrition Examination Survey III. Ophtalmology 1999;106: 1056–65.
9. Friedman DS, O’Colmain BJ, Munoz B, et al. Prevalence of agerelated macular degeneration in the United States. Arch Ophthalmol 2004;122(4):564–72.
10. Johnson EJ. A possible role for lutein and zeaxanthin in cognitive function in the elderly. Am J Clin Nutr 2012;96(5): 1161S–5S.
11. Johnson EJ, Vishwanathan R, Johnson MA, et al. Relationship between serum and brain carotenoids, α-tocopherol, and retinol concentrations and cognitive performance in the oldest old from the Georgia Centenarian Study. J Aging Res 2013;2013:13.
12. Craft NE, Haitema TB, Garnett KM, Fitch KA, Dorey CK. Carotenoid, tocopherol, and retinol concentrations in elderly human brain. J Nutr Health Aging 2004;8(3):156–62.
13. Vishwanathan R, Kuchan MJ, Sen S, Johnson EJ. Lutein is the predominant carotenoid in infant brain: preterm infants have decreased concentrations of brain carotenoids. J Pediatr Gastroenterol Nutr 2014;59(5):659–65; 10.1097/MPG.0000000000000389.
14. Johnson EJ, McDonald K, Caldarella SM, Chung H-Y, Troen AM, Snodderly DM. Cognitive findings of an exploratory trial of docosahexaenoic acid and lutein supplementation in older women. Nutr Neurosci 2008;11(2):75–83.
15. Vishwanathan R, Iannaccone A, Scott TM, et al. Macular pigment optical density is related to cognitive function in older people. Age Ageing 2014;43(2):271–5.
16. Feeney J, Finucane C, Savva GM, et al. Low macular pigment optical density is associated with lower cognitive performance in a large, population-based sample of older adults. Neurobiol Aging 2013;34(11):2449–56.
17. Renzi LM, Dengler MJ, Puente A, Miller SL, Hammond BR. Relationships between macular pigment optical density and cognitive function in unimpaired and mildly cognitively impaired older adults. Neurobiol Aging 2014;35(7):1695–9.
18. Vishwanathan R, Neuringer M, Snodderly DM, Schalch W, Johnson EJ. Macular lutein and zeaxanthin are related to brain lutein and zeaxanthin in primates. Nutr Neurosci 2013; 16(1):21–9.
19. Wooten BR, Hammond BR, Land RI, Snodderly DM. A practical method for measuring macular pigment optical density. Invest Ophthalmol Vis Sci 1999;40(11):2481–9.
20. Park JH, Hwang HJ, Kim MK, Lee-Kim YC. Effects of dietary fatty acids and vitamin E supplementation on antioxidant vitamin status of the second generation rat brain sections. Korean J Nutr 2001;34(7):754–61.
21. Handelman GJ, Snodderly DM, Krinsky NI, Russett MD. Biological control of primate macular pigment. Biochemical and densitometric studies. Invest Ophthalmol Vis Sci 1991;32:257–67.
22. Handelman GJ, Dratz EA, Reay CC, van Kuijk JG. Carotenoids in the human macula and whole retina. Invest Ophthalmol Vis Sci 1988;29(6):850–5.
23. Bernstein PS, Khachik F, Carvalho LS, Muir GJ, Zhao DY, Katz NB. Identification and quantitation of carotenoids and their metabolites in the tissues of the human eye. Exp Eye Res 2001; 72(3):215–23.
24. Li B, Vachali P, Bernstein PS. Human ocular carotenoid-binding proteins. Photochem Photobiol Sci 2010;9(11):1418–25.
25. Li B, Vachali P, Frederick JM, Bernstein PS. Identification of StARD3 as a lutein-binding protein in the macula of the primate retina. Biochemistry 2011;50(13):2541–9.